David Hoang
Stock Analyst at Deutsche Bank
(4.78)
# 566
Out of 4,509 analysts
117
Total ratings
65.9%
Success rate
33.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Hoang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $226 → $270 | $236.97 | +13.94% | 6 | Jul 9, 2026 | |
| HRMY Harmony Biosciences Holdings | Maintained: Hold | $30 → $36 | $35.54 | +1.29% | 7 | Jun 30, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintained: Buy | $29 → $37 | $25.50 | +45.10% | 10 | Jun 29, 2026 | |
| BHVN Biohaven | Rated: Buy | $65 → $20 | $15.17 | +31.84% | 2 | Jun 26, 2026 | |
| SYRE Spyre Therapeutics | Maintained: Buy | $102 → $135 | $93.73 | +44.03% | 4 | Jun 23, 2026 | |
| APGE Apogee Therapeutics | Downgraded: Hold | $118 → $135 | $133.82 | +0.88% | 4 | Jun 23, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Buy | $420 → $374 | $314.56 | +18.90% | 9 | Jun 2, 2026 | |
| DNLI Denali Therapeutics | Maintained: Buy | $35 → $31 | $26.48 | +17.07% | 9 | May 22, 2026 | |
| NBIX Neurocrine Biosciences | Maintained: Hold | $140 → $155 | $174.10 | -10.97% | 10 | May 7, 2026 | |
| AXSM Axsome Therapeutics | Rated: Buy | $281 → $280 | $228.28 | +22.66% | 9 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $12 → $14 | $18.82 | -25.61% | 23 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $4.97 | +141.45% | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $90 | $67.72 | +32.90% | 9 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 → $45 | $51.87 | -13.24% | 3 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $2.64 | n/a | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $9.72 | n/a | 3 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $3.24 | n/a | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $220 | $288.06 | n/a | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $74.11 | n/a | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $24 → $3 | $0.1441 | n/a | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $0.693 | n/a | 1 | Sep 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $73 | $363.44 | n/a | 1 | Mar 12, 2020 |
Jazz Pharmaceuticals
Jul 9, 2026
Maintained: Buy
Price Target: $226 → $270
Current: $236.97
Upside: +13.94%
Harmony Biosciences Holdings
Jun 30, 2026
Maintained: Hold
Price Target: $30 → $36
Current: $35.54
Upside: +1.29%
ACADIA Pharmaceuticals
Jun 29, 2026
Maintained: Buy
Price Target: $29 → $37
Current: $25.50
Upside: +45.10%
Biohaven
Jun 26, 2026
Rated: Buy
Price Target: $65 → $20
Current: $15.17
Upside: +31.84%
Spyre Therapeutics
Jun 23, 2026
Maintained: Buy
Price Target: $102 → $135
Current: $93.73
Upside: +44.03%
Apogee Therapeutics
Jun 23, 2026
Downgraded: Hold
Price Target: $118 → $135
Current: $133.82
Upside: +0.88%
Praxis Precision Medicines
Jun 2, 2026
Maintained: Buy
Price Target: $420 → $374
Current: $314.56
Upside: +18.90%
Denali Therapeutics
May 22, 2026
Maintained: Buy
Price Target: $35 → $31
Current: $26.48
Upside: +17.07%
Neurocrine Biosciences
May 7, 2026
Maintained: Hold
Price Target: $140 → $155
Current: $174.10
Upside: -10.97%
Axsome Therapeutics
May 5, 2026
Rated: Buy
Price Target: $281 → $280
Current: $228.28
Upside: +22.66%
Mar 26, 2026
Maintained: Sell
Price Target: $12 → $14
Current: $18.82
Upside: -25.61%
Mar 26, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $4.97
Upside: +141.45%
Mar 10, 2026
Maintained: Buy
Price Target: $60 → $90
Current: $67.72
Upside: +32.90%
Nov 13, 2025
Maintained: Buy
Price Target: $52 → $45
Current: $51.87
Upside: -13.24%
Jul 25, 2024
Initiated Coverage: Buy
Price Target: $7
Current: $2.64
Upside: n/a
Jul 17, 2024
Maintained: Buy
Price Target: $16
Current: $9.72
Upside: n/a
Mar 6, 2024
Maintained: Buy
Price Target: $16
Current: $3.24
Upside: n/a
Apr 26, 2023
Initiated Coverage: Hold
Price Target: $220
Current: $288.06
Upside: n/a
Apr 26, 2023
Initiated Coverage: Buy
Price Target: $80
Current: $74.11
Upside: n/a
Dec 7, 2022
Downgraded: Hold
Price Target: $24 → $3
Current: $0.1441
Upside: n/a
Sep 30, 2020
Maintained: Buy
Price Target: $19
Current: $0.693
Upside: n/a
Mar 12, 2020
Initiated Coverage: Buy
Price Target: $73
Current: $363.44
Upside: n/a